Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.32 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.31 |
| ▸ | LCK | P06239 | 1/20 | 0.31 |
| ▸ | FYN | P06241 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21788102 | 0.71 | TSHR (0.33) | TP53FFAR3LCKFYN | |
| SCHEMBL6249962 | 0.71 | TP53 (0.39) | TP53MEN1KMT2ASLC7A5FFAR3 | |
| SCHEMBL42467 | 0.71 | TP53 (0.39) | TP53MEN1KMT2ASLC7A5FFAR3 | |
| SCHEMBL8593198 | 0.69 | — | — | |
| SCHEMBL638833 | 0.69 | TP53 (0.37) | TP53MEN1KMT2ASLC7A5 | |
| SCHEMBL22199559 | 0.69 | TP53 (0.30) | TP53 | |
| SCHEMBL968744 | 0.69 | — | — | |
| SCHEMBL1494555 | 0.69 | — | — | |
| SCHEMBL672963 | 0.69 | TP53 (0.37) | TP53MEN1KMT2ASLC7A5 | |
| SCHEMBL673528 | 0.69 | TP53 (0.37) | TP53MEN1KMT2ASLC7A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 348 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1877513-B1 | CAP LINERS, CLOSURES AND GASKETS FROM MULTI-BLOCK POLYMERS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2019-05-08 | — | — | EP | claimed |
| US-20180222909-A1 | PROCESS FOR THE PREPARATION OF IBRUTINIB AND NEW SYNTHESIS INTERMEDIATE | OLON SPA (IT) | 2018-08-09 | — | — | US | claimed |
| EP-3328863-A1 | PROCESS FOR THE PREPARATION OF IBRUTINIB AND NEW SYNTHESIS INTERMEDIATE | OLON S.p.A. (IT) | 2018-06-06 | — | — | EP | claimed |
| WO-2017017619-A1 | PROCESS FOR THE PREPARATION OF IBRUTINIB AND NEW SYNTHESIS INTERMEDIATE | OLON S.P.A. (IT) | 2017-02-02 | — | — | WO | claimed |
| US-7671106-B2 | Cap liners, closures and gaskets from multi-block polymers | DOW GLOBAL TECHNOLOGIES INC. (US) | 2010-03-02 | — | — | US | claimed |
| JP-2008545017-A | — | — | 2008-12-11 | — | — | JP | claimed |
| EP-1877513-A2 | CAP LINERS, CLOSURES AND GASKETS FROM MULTI-BLOCK POLYMERS | Dow Global Technologies Inc. (US) | 2008-01-16 | — | — | EP | claimed |
| WO-2006113000-A2 | CAP LINERS, CLOSURES AND GASKETS FROM MULTI-BLOCK POLYMERS | DOW GLOBAL TECHNOLOGIES INC. (US) | 2006-10-26 | — | — | WO | claimed |
| US-20060199911-A1 | Cap liners, closures and gaskets from multi-block polymers | DOW GLOBAL TECHNOLOGIES INC. (US) | 2006-09-07 | — | — | US | claimed |
| US-6617295-B2 | Foaming or expansion of the resin brought about by molded particles of blowing agent, wax binder and filler enables the polymeric material to flow through the polymer processing machinery under lower pressures | POLYONE CORPORATION | 2003-09-09 | — | — | US | claimed |
| WO-1999035187-A1 | REWORKABLE EPOXY UNDERFILL ENCAPSULANTS | GEORGIA TECH RESEARCH CORPORATION (US) | 1999-07-15 | — | — | WO | claimed |
| WO-1999025353-A1 | THERAPEUTIC USES OF TRIAZOLO-PYRIDAZINE DERIVATIVES | MERCK SHARP & DOHME LIMITED (GB) | 1999-05-27 | — | — | WO | claimed |
| EP-0891390-A1 | FOAMED GASKETS MADE FROM HOMOGENEOUS OLEFIN POLYMERS | THE DOW CHEMICAL COMPANY (US) | 1999-01-20 | — | — | EP | claimed |
| US-5723507-A | ETHYLENE POLYMERS FOR GASKET SEALS | THE DOW CHEMICAL COMPANY (US) | 1998-03-03 | — | — | US | claimed |
| WO-1998005731-A1 | GASKETS MADE FROM OLEFIN POLYMERS | THE DOW CHEMICAL COMPANY (US) | 1998-02-12 | — | — | WO | claimed |
| WO-1997033935-A1 | FOAMED GASKETS MADE FROM HOMOGENEOUS OLEFIN POLYMERS | THE DOW CHEMICAL COMPANY (US) | 1997-09-18 | — | — | WO | claimed |
| US-5203793-A | Conformable cushioning and stability device for articles of footwear | LYDEN ROBERT M (US) | 1993-04-20 | — | — | US | claimed |
| EP-0214552-B1 | FOAMABLE MOLDINGS COMPOSITIONS | MOBAY CORPORATION (US) | 1990-09-26 | — | — | EP | claimed |
| US-4751250-A | Process for foaming thermoplastic | MOBAY CORPORATION (US) | 1988-06-14 | — | — | US | claimed |
| US-4737523-A | BLEND CONTAINING ANHYDRIDE-IMPACT RESISTANCE | MOBAY CORPORATION (US) | 1988-04-12 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180222909-A1 | PROCESS FOR THE PREPARATION OF IBRUTINIB AND NEW SYNTHESIS INTERMEDIATE | BTK, SYK, BCL6B | TP53 384/4885MEN1 1203/4885KMT2A 674/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.